Advance Care Planning Coaching for Patients With Chronic Kidney Disease
NCT ID: NCT03506087
Last Updated: 2020-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
288 participants
INTERVENTIONAL
2018-05-15
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: In patients aged 55 or older with stage 3-5 Chronic Kidney Disease cared for in a CKD outpatient clinic, an advance care planning process that involves in-person meetings with a trained ACP coach will be more effective than providing patients with printed educational materials alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advance Care Planning With Older Patients Who Have End-stage Kidney Disease
NCT02631200
Integrating Conservative Kidney Management Options and Advance Care Planning Into a Pre-Dialysis Educational Program
NCT03229811
Chronic Kidney Disease-Education (CKD-EDU)
NCT06410144
Automated Clinical Reminders in the Care of Chronic Kidney Disease Patients
NCT00688285
Healthy Transitions in Late Stage Kidney Disease
NCT02085837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ADVANCE CARE PLANNING COACHING SESSION (intervention arm only): Participants in the intervention arm will receive a 60-minute in-person coaching session. The advance care planning coach, trained in motivational interviewing, will use a flexible script and checklist to assess the participant's readiness to engage in advance care planning and guide the participant forward in the process, proceeding at the participant's pace. Some participants may complete advance directives while others will not get that far. The coach will document the clinical aspects of the discussion in the participant's medical chart according to clinic protocol and the research aspects in the participant tracking instruments. The ACP coach may arrange for one or more follow-up sessions as needed, typically conducted by telephone.
FOLLOW-UP ASSESSMENT SURVEY (both study arms): Approximately 14 weeks after the baseline visit, research staff will contact the participant to administer a follow-up assessment survey.
FOLLOW-UP CHART REVIEW: Approximately 16 weeks after the baseline visit, research staff will review the participant's medical chart to assess documentation of advance care planning activities, medical and health outcomes, and use of medical and palliative care services.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coaching
Receives printed advance care planning (ACP) materials. Receives advance care planning coaching session. May receive followup coaching session, typically by telephone.
Advance care planning coaching session.
A 60-minute in-person coaching session. The advance care planning coach, trained in motivational interviewing, will use a flexible script and checklist to assess the participant's readiness to engage in advance care planning and guide the participant forward in the process, proceeding at the participant's pace. Some participants may complete advance directives while others will not get that far. Some participants may receive a follow-up session 2-4 weeks later. Typically this 20 to 30-minute conversation will be by phone, but it may be conducted at the clinic as indicated for the participant.
Printed advance care planning materials
Participants are provided with a folder containing an advance care planning guide developed by the Coalition for the Supportive Care of Kidney Patients for persons with Chronic Kidney Disease. The patient folder also contains the advance directive form used by the clinic that is appropriate to the state.
Enhanced Control
Receives printed advance care planning materials only.
Printed advance care planning materials
Participants are provided with a folder containing an advance care planning guide developed by the Coalition for the Supportive Care of Kidney Patients for persons with Chronic Kidney Disease. The patient folder also contains the advance directive form used by the clinic that is appropriate to the state.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Advance care planning coaching session.
A 60-minute in-person coaching session. The advance care planning coach, trained in motivational interviewing, will use a flexible script and checklist to assess the participant's readiness to engage in advance care planning and guide the participant forward in the process, proceeding at the participant's pace. Some participants may complete advance directives while others will not get that far. Some participants may receive a follow-up session 2-4 weeks later. Typically this 20 to 30-minute conversation will be by phone, but it may be conducted at the clinic as indicated for the participant.
Printed advance care planning materials
Participants are provided with a folder containing an advance care planning guide developed by the Coalition for the Supportive Care of Kidney Patients for persons with Chronic Kidney Disease. The patient folder also contains the advance directive form used by the clinic that is appropriate to the state.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 55 or older
* English speaking
* Patient at participating CKD clinic
Exclusion Criteria
* Kidney transplant recipient
* Cognitively impaired or otherwise not competent to participate (as deemed by treating nephrologist and research staff)
* Participation contra-indicated for patient's health (as deemed by treating nephrologist)
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Quality Insights
UNKNOWN
Renal & Transplant Associates of New England
UNKNOWN
Mountain Kidney and Hypertension Associates
UNKNOWN
University of Pittsburgh
OTHER
Medstar Health Research Institute
OTHER
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dale Lupu
Associate Research Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dale E Lupu, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
The George Washington University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
Renal & Transplant Associates of New England
Springfield, Massachusetts, United States
Mountain Kidney & Hypertension Associates
Asheville, North Carolina, United States
University of Pittsburgh Medical Center Kidney Clinic
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lupu DE, Aldous A, Anderson E, Schell JO, Groninger H, Sherman MJ, Aiello JR, Simmens SJ. Advance Care Planning Coaching in CKD Clinics: A Pragmatic Randomized Clinical Trial. Am J Kidney Dis. 2022 May;79(5):699-708.e1. doi: 10.1053/j.ajkd.2021.08.019. Epub 2021 Oct 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GW091617
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.